Resumo

LORENZO, Jessica E; ROSA, Javier E; POSADAS MARTINEZ, María Lourdes  e  JAUREGUI, José R. Sarcopenia and its relevance in clinical practice. Rev. argent. reumatolg. [online]. 2022, vol.33, n.3, pp.162-172. ISSN 0327-4411.  http://dx.doi.org/10.47196/rar.v33i3.674.

Sarcopenia is defined as a combination of low muscle strength and mass with muscle function impairment that affects the population at different age ranges for different reasons. The global prevalence at the elderly was estimated at 10% (95% CI: 8-12%) in men and 10% (95% CI: 8-13%) in women. In recent years, the detection of sarcopenia in rheumatic diseases has become relevant. The aim of this revision was to develop a review regarding: a) recommendations for the diagnosis of sarcopenia; b) most useful tools for detection in clinical practice and research; c) relationship with some rheumatic diseases. According to the latest European Sarcopenia Consensus, in clinical practice, the search must start when the patient reports symptoms and signs (weakness, slow walking, muscle wasting, disease that leads to muscle loss, etc.). For the elderly population the SARC-F test is recommended as a screening tool. Several tests have established cut-off points to be used to diagnose low muscle strength, decrease in muscle mass or physical performance impairment. The relevance of early diagnosis of sarcopenia is based on the clinical, economic, social impact and also on functionality and quality of life in people, particularly in those with rheumatic diseases.

Palavras-chave : sarcopenia; muscle mass; dynapenia; muscle strength; elderly people.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )